US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.310
  • -0.060-4.38%
Close Mar 21 16:00 ET
  • 1.310
  • 0.0000.00%
Post 20:01 ET
108.70MMarket Cap-0.45P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.09%-210.28M
-128.25%-50.76M
-48.31%-52.59M
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
Net income from continuing operations
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
Operating gains losses
--149K
--10K
----
----
----
----
----
--0
--0
--1.58M
Depreciation and amortization
-4.21%5.81M
-5.80%1.38M
5.61%1.6M
-7.79%1.42M
-8.74%1.41M
-4.31%6.06M
-7.04%1.47M
-5.61%1.51M
-3.63%1.54M
-0.90%1.54M
Other non cash items
11.22%1.78M
--2.19M
--0
----
----
--1.6M
----
----
----
----
Change In working capital
316.44%3.45M
-49.61%-12.1M
-4.89%4.34M
245.81%6.41M
-24.13%4.8M
-119.50%-1.59M
-167.27%-8.09M
777.31%4.56M
-158.08%-4.4M
153.01%6.33M
-Change in receivables
-20.57%-6.08M
-107.86%-16.14M
186.76%118K
100.05%1K
102.77%9.94M
-3.36%-5.04M
-54.53%-7.77M
-122.93%-136K
-410.17%-2.04M
543.71%4.9M
-Change in prepaid assets
2,331.47%4.4M
388.12%2.79M
570.00%1.07M
326.19%2.14M
-203.15%-1.61M
-43.80%-197K
-118.02%-968K
-86.83%160K
-17.06%-947K
1,673.74%1.56M
-Change in payables and accrued expense
256.10%9.34M
577.37%10.15M
-105.04%-239K
179.78%3.58M
-577.01%-4.15M
-82.37%2.62M
-89.05%1.5M
1,119.35%4.74M
-176.49%-4.49M
120.66%870K
-Change in other current assets
-32.28%4.49M
170.66%3.23M
72.19%4.09M
-237.36%-4.17M
-76.95%1.34M
141.67%6.63M
75.70%-4.58M
227.17%2.37M
17.69%3.03M
162.51%5.8M
-Change in other current liabilities
95.85%-233K
-198.42%-3.67M
72.89%-698K
10,012.50%4.85M
89.38%-723K
-131.93%-5.61M
-83.55%3.73M
-346.88%-2.58M
101.65%48K
-111.76%-6.81M
-Change in other working capital
---8.46M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-59.09%-210.28M
-128.25%-50.76M
-48.31%-52.59M
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
Investing cash flow
Cash flow from continuing investing activities
4,445.91%162.15M
-50.74%30.96M
181.68%83.98M
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
Net PPE purchase and sale
-87.03%-8.83M
58.68%-540K
-1,122.18%-2.92M
-162.12%-3.49M
-1.68%-1.87M
-15.10%-4.72M
-109.46%-1.31M
61.07%-239K
-117.10%-1.33M
18.15%-1.84M
Net investment purchase and sale
17,204.86%170.97M
-50.90%31.5M
184.71%86.9M
287.34%55.45M
-111.45%-2.87M
-99.16%988K
338.43%64.15M
-214.18%-102.58M
522.52%14.32M
-57.17%25.11M
Cash from discontinued investing activities
Investing cash flow
4,445.91%162.15M
-50.74%30.96M
181.68%83.98M
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
Financing cash flow
Cash flow from continuing financing activities
-52.54%56.03M
10,700.19%55.51M
0
-99.73%322K
192K
9,093.07%118.04M
-16.96%514K
0
31,923.16%117.53M
0
Net common stock issuance
--0
--0
--0
----
----
--117.08M
--0
--0
----
----
Proceeds from stock option exercised by employees
-18.44%783K
-47.67%269K
--0
-27.80%322K
--192K
-25.23%960K
-16.96%514K
--0
21.53%446K
--0
Net other financing activities
--55.24M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-52.54%56.03M
10,700.19%55.51M
--0
-99.73%322K
--192K
9,093.07%118.04M
-16.96%514K
--0
31,923.16%117.53M
--0
Net cash flow
Beginning cash position
-12.29%127.53M
15.38%99.71M
-69.60%68.32M
-44.99%73.1M
-12.29%127.53M
-29.89%145.4M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
-29.89%145.4M
Current changes in cash
144.15%7.89M
-13.15%35.71M
122.70%31.39M
-105.21%-4.79M
-335.37%-54.43M
71.18%-17.87M
159.43%41.11M
-434.79%-138.28M
321.30%91.8M
-269.80%-12.5M
End cash Position
6.19%135.42M
6.19%135.42M
15.38%99.71M
-69.60%68.32M
-44.99%73.1M
-12.29%127.53M
-12.29%127.53M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
Free cash flow
-60.05%-219.11M
-117.87%-51.3M
-55.50%-55.51M
-51.22%-60.56M
-37.59%-51.74M
24.56%-136.9M
45.11%-23.55M
26.57%-35.7M
-4.07%-40.04M
26.94%-37.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.09%-210.28M-128.25%-50.76M-48.31%-52.59M-47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M
Net income from continuing operations -54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M
Operating gains losses --149K--10K----------------------0--0--1.58M
Depreciation and amortization -4.21%5.81M-5.80%1.38M5.61%1.6M-7.79%1.42M-8.74%1.41M-4.31%6.06M-7.04%1.47M-5.61%1.51M-3.63%1.54M-0.90%1.54M
Other non cash items 11.22%1.78M--2.19M--0----------1.6M----------------
Change In working capital 316.44%3.45M-49.61%-12.1M-4.89%4.34M245.81%6.41M-24.13%4.8M-119.50%-1.59M-167.27%-8.09M777.31%4.56M-158.08%-4.4M153.01%6.33M
-Change in receivables -20.57%-6.08M-107.86%-16.14M186.76%118K100.05%1K102.77%9.94M-3.36%-5.04M-54.53%-7.77M-122.93%-136K-410.17%-2.04M543.71%4.9M
-Change in prepaid assets 2,331.47%4.4M388.12%2.79M570.00%1.07M326.19%2.14M-203.15%-1.61M-43.80%-197K-118.02%-968K-86.83%160K-17.06%-947K1,673.74%1.56M
-Change in payables and accrued expense 256.10%9.34M577.37%10.15M-105.04%-239K179.78%3.58M-577.01%-4.15M-82.37%2.62M-89.05%1.5M1,119.35%4.74M-176.49%-4.49M120.66%870K
-Change in other current assets -32.28%4.49M170.66%3.23M72.19%4.09M-237.36%-4.17M-76.95%1.34M141.67%6.63M75.70%-4.58M227.17%2.37M17.69%3.03M162.51%5.8M
-Change in other current liabilities 95.85%-233K-198.42%-3.67M72.89%-698K10,012.50%4.85M89.38%-723K-131.93%-5.61M-83.55%3.73M-346.88%-2.58M101.65%48K-111.76%-6.81M
-Change in other working capital ---8.46M------------------------------------
Cash from discontinued investing activities
Operating cash flow -59.09%-210.28M-128.25%-50.76M-48.31%-52.59M-47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M
Investing cash flow
Cash flow from continuing investing activities 4,445.91%162.15M-50.74%30.96M181.68%83.98M300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M
Net PPE purchase and sale -87.03%-8.83M58.68%-540K-1,122.18%-2.92M-162.12%-3.49M-1.68%-1.87M-15.10%-4.72M-109.46%-1.31M61.07%-239K-117.10%-1.33M18.15%-1.84M
Net investment purchase and sale 17,204.86%170.97M-50.90%31.5M184.71%86.9M287.34%55.45M-111.45%-2.87M-99.16%988K338.43%64.15M-214.18%-102.58M522.52%14.32M-57.17%25.11M
Cash from discontinued investing activities
Investing cash flow 4,445.91%162.15M-50.74%30.96M181.68%83.98M300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M
Financing cash flow
Cash flow from continuing financing activities -52.54%56.03M10,700.19%55.51M0-99.73%322K192K9,093.07%118.04M-16.96%514K031,923.16%117.53M0
Net common stock issuance --0--0--0----------117.08M--0--0--------
Proceeds from stock option exercised by employees -18.44%783K-47.67%269K--0-27.80%322K--192K-25.23%960K-16.96%514K--021.53%446K--0
Net other financing activities --55.24M------------------------------------
Cash from discontinued financing activities
Financing cash flow -52.54%56.03M10,700.19%55.51M--0-99.73%322K--192K9,093.07%118.04M-16.96%514K--031,923.16%117.53M--0
Net cash flow
Beginning cash position -12.29%127.53M15.38%99.71M-69.60%68.32M-44.99%73.1M-12.29%127.53M-29.89%145.4M-59.73%86.42M29.67%224.69M-38.12%132.9M-29.89%145.4M
Current changes in cash 144.15%7.89M-13.15%35.71M122.70%31.39M-105.21%-4.79M-335.37%-54.43M71.18%-17.87M159.43%41.11M-434.79%-138.28M321.30%91.8M-269.80%-12.5M
End cash Position 6.19%135.42M6.19%135.42M15.38%99.71M-69.60%68.32M-44.99%73.1M-12.29%127.53M-12.29%127.53M-59.73%86.42M29.67%224.69M-38.12%132.9M
Free cash flow -60.05%-219.11M-117.87%-51.3M-55.50%-55.51M-51.22%-60.56M-37.59%-51.74M24.56%-136.9M45.11%-23.55M26.57%-35.7M-4.07%-40.04M26.94%-37.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
13.460
New Fortress Energy
NFE
11.170
Cars.com
CARS
11.640
4
Halozyme Therapeutics
HALO
65.160
5
Collegium Pharmaceutical
COLL
30.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Earnings Season Underway
Earnings season is here. What to know?